Site Search
Search Results
Lawmakers can improve the odds in New Yorkers' battles against cancer
... burden of their diagnosis. The next step in minimizing cancer’s burden should be to ensure that New Yorkers who could benefit have access to biomarker testing--a critical component of precision medicine. The results of these biomarker tests can help match patients with the right treatment at the right time. Recent studies show that biomarker testing can improve outcomes ...
Cervical Cancer Awareness Month 2023: Pennsylvania Ranks Fifth in Cervical Cancer Deaths among States
... doing so will ensure that Pennsylvania can, with each year, screen more residents and prevent disease progression. Expand access to biomarker testing for patients covered by state-regulated health plans, including Medicaid. Insight gained from biomarker testing can be used to help guide medical treatment in cervical and other cancers. Biomarker testing is often used to connect patients ...
Cervical Cancer Awareness Month 2023: New York Ranks Fourth in Cervical Cancer Deaths among States
... lost in 2017, New York would recover definitive gaps in access to early detection services for cervical cancer. 2. Expand access to biomarker testing for patients covered by state-regulated health plans, including Medicaid. Insight gained from biomarker testing can be used to help guide medical treatment in cervical and other cancers. Biomarker testing is often used to connect patients ...
Steps Governor Hochul Can Take to Make New York a Leader in Health Equity
... a bold step in health policy and greater accessibility to precision medicine technologies. ACS CAN proposes that New York improve access to biomarker testing—a technology that enables oncologists to provide the right treatment for the right patient at the right time. Allowing oncologists to ... treatment with precision medicine can lead to better outcomes. Right now, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker ...
Legislative Action Needed to Reduce the Burden of Cancer on New Jerseyans
... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...
2024 Oregon Policy Forum
... will host their annual policy forum in person on Oct. 10th, 2024. This year we will focus our conversation on access and insurance coverage of biomarker testing in Oregon. The American Cancer Society Cancer Action Network (ACS CAN) is the nation’s leading advocacy organization working every day to ...
Governor Hochul to Receive Policy Wish List During Santa’s Visit to State Capitol
... by fully funding the NYS Cancer Services Program Ensure that every patient who needs it has access to precision medicine by improving access to biomarker testing WHY : As children across New York prepare and post their Christmas wish lists, Santa Clause is stepping away from the North Pole and ...
Advocates Set Sights on Cancer Prevention & Detection in 2024, Respond to Governor’s Budget with Avenues to Reduce Cancer Burden in NY
... Relations Director Michael Davoli: “In 2023, New York State delivered for its residents, prioritizing access to care with the passage of the biomarker testing bill. This legislation will equip countless New Yorkers who have received a cancer diagnosis with critical information about their disease ... their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it. 0 Four weeks after historic biomarker testing bill was signed into law, ACS CAN reacts to Governor’s budget and unveils its legislative vision for 2024 Advocates Set Sights ...